Literature DB >> 10690305

Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.

T Nakajima1, T Furukawa, Y Hirano, T Tanaka, H Sakurada, T Takahashi, R Nagai, T Itoh, Y Katayama, Y Nakamura, M Hiraoka.   

Abstract

OBJECTIVE: Recently, a novel missense mutation (R534C) in the S4 region of human ether-a-go-go-related gene (HERG) was identified in one Japanese LQT2 family. The S4 region presumably functions as a voltage sensor. However, it has not yet been addressed whether the S4 region of HERG indeed functions as a voltage sensor, and whether these residues play any role in abnormal channel function in cardiac repolarization.
METHODS: We characterized the electrophysiological properties of the R534C mutation using the heterologous expression system in Xenopus oocytes. Whole cell currents were recorded in oocytes injected with wild-type cRNA, R534C cRNA, or a combination of both.
RESULTS: Clinical features--QTc intervals of all affected patients with R534C mutation in HERG are prolonged ranging from 460 to 680 ms (averaged QTc interval > 540 ms). One member of this family had experienced sudden cardiac arrest, and other suffered from recurrent palpitation. Electrophysiology--Oocytes injected with R534C cRNA did express functional channels with altered channel gating. Kinetic analyses revealed that the R534C mutation shifted the voltage-dependence of HERG channel activation to a negative direction, accelerated activation and deactivation time course, and reduced steady-state inactivation. Quantitative analyses revealed that this mutation did not cause apparent dominant-negative suppression. Computer simulation--Incorporating the kinetic alterations of R534C, however, did not reproduce prolonged action potential duration (APD).
CONCLUSIONS: The data revealed that arginine at position 534 in the S4 region of HERG is indeed involved in voltage-dependence of channel activation as a voltage sensor. Our examination indicated that HERG current suppression in R534C mutation was the least severe among other mutations that have been electrophysiologically examined, while affected patients did show significant QT prolongation. This suggest that another unidentified factor(s) that prolong APD might be present.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690305     DOI: 10.1016/s0008-6363(99)00195-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  Molecular basis of slow activation of the human ether-a-go-go related gene potassium channel.

Authors:  Rajesh N Subbiah; Catherine E Clarke; David J Smith; JingTing Zhao; Terence J Campbell; Jamie I Vandenberg
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

2.  Electrophysiological study of V535M hERG mutation of LQT2.

Authors:  Chunyan Shao; Yan Lu; Mohan Liu; Qi Chen; Yunfeng Lan; Yan Liu; Min Lin; Yang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

3.  A recombinant N-terminal domain fully restores deactivation gating in N-truncated and long QT syndrome mutant hERG potassium channels.

Authors:  Ahleah S Gustina; Matthew C Trudeau
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

4.  Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)).

Authors:  Y Mori; M Wakamori; S Oda; C F Fletcher; N Sekiguchi; E Mori; N G Copeland; N A Jenkins; K Matsushita; Z Matsuyama; K Imoto
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

5.  Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.

Authors:  Christie M McBride; Ashley M Smith; Jennifer L Smith; Allison R Reloj; Ellyn J Velasco; Jonathan Powell; Claude S Elayi; Daniel C Bartos; Don E Burgess; Brian P Delisle
Journal:  J Membr Biol       Date:  2013-04-02       Impact factor: 1.843

6.  A novel splice mutation of HERG in a Chinese family with long QT syndrome.

Authors:  Yun-peng Shang; Xu-dong Xie; Xing-xiang Wang; Jun-zhu Chen; Jian-hua Zhu; Qian-min Tao; Liang-rong Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

7.  Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells.

Authors:  Kun Lin; Yu-qi Liu; Bin Xu; Jin-liao Gao; Yi-cheng Fu; Yu Chen; Qiao Xue; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

8.  Fluorescence-tracking of activation gating in human ERG channels reveals rapid S4 movement and slow pore opening.

Authors:  Zeineb Es-Salah-Lamoureux; Robert Fougere; Ping Yu Xiong; Gail A Robertson; David Fedida
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  Clinical and electrophysiological characterization of a novel mutation R863X in HERG C-terminus associated with long QT syndrome.

Authors:  Siyong Teng; Lijuan Ma; Yingxue Dong; Chunxia Lin; Jue Ye; Robert Bähring; Vitya Vardanyan; Yanzong Yang; Zhihu Lin; Olaf Pongs; Rutai Hui
Journal:  J Mol Med (Berl)       Date:  2004-01-09       Impact factor: 4.599

10.  A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.

Authors:  Daniel C Bartos; John R Giudicessi; David J Tester; Michael J Ackerman; Seiko Ohno; Minoru Horie; Michael H Gollob; Don E Burgess; Brian P Delisle
Journal:  Heart Rhythm       Date:  2013-11-21       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.